🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the interest of regorafenib in combination of metronom...
Status
Recruiting
Location
CHU de Besançon
Start Date
2023-05-09
Trial ID
NCT05462613
The objective of this study is to demonstrate the clinical performance of t...
Status
Completed
Location
NECCR Primacare Research, LLC
Start Date
2017-06-06
Trial ID
NCT03238274
Treatments Being Tested
The over-all aim of this 10-week randomized-controlled study, taking place ...
Status
Completed
Location
University of Copenhagen
Start Date
2020-10-26
Trial ID
NCT04590989
Treatments Being Tested
The main objective of the study is to describe the temporal curve of COVID-...
Status
Completed
Location
CHU Orléans
Start Date
2020-08-27
Trial ID
NCT04750720
Treatments Being Tested
This is a randomized, multi-center, open-label Phase II clinical trial to d...
Status
Withdrawn
Location
Geisinger Medical Center
Start Date
2012-09
Trial ID
NCT01524068
Treatments Being Tested
This research will be conducted nationwide in patients with autoimmune gast...
Status
Unknown
Location
Shanghai Institute of Digestive Disease
Start Date
2022-06-19
Trial ID
NCT05820607
Treatments Being Tested
In this study, the investigators address the research question of whether p...
Status
Completed
Location
Malaysian Palm Oil Board
Start Date
2009-02
Trial ID
NCT00941837
Treatments Being Tested
This cohort study aims to describe the adverse events related to the use of...
Status
Recruiting
Location
Hospices Civils de Lyon
Start Date
2022-05-09
Trial ID
NCT04650607
Treatments Being Tested
Occult metastasis at the time of surgery is a major driver of poor outcomes...
Status
Completed
Location
City of Hope Medical Center
Start Date
2024-06-21
Trial ID
NCT07224737
Treatments Being Tested
This phase III trial compares the effect of 3 study approaches in preventin...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-06-06
Trial ID
NCT05642611